
BHC
CAS No. 342387-19-3
BHC( Myosin inhibitor BHC )
Catalog No. M14163 CAS No. 342387-19-3
BHC (Myosin inhibitor BHC) is a small-molecule screen of skeletal muscle myosin inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBHC
-
NoteResearch use only, not for human use.
-
Brief DescriptionBHC (Myosin inhibitor BHC) is a small-molecule screen of skeletal muscle myosin inhibitor.
-
DescriptionBHC (Myosin inhibitor BHC) is a small-molecule screen of skeletal muscle myosin inhibitor that suppresses movements without affecting membrane currents; selectively blocks nerve-evoked muscle contraction without affecting neurotransmitter release.
-
In Vitro——
-
In Vivo——
-
SynonymsMyosin inhibitor BHC
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMyosin
-
RecptorMyosin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number342387-19-3
-
Formula Weight259.305
-
Molecular FormulaC15H17NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name3-(N-butylethanimidoyl)-4-hydroxy-2H-chromen-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Heredia DJ, et al. Front Cell Neurosci. 2016 Dec 1;10:276.
2. Cheung A, et al. Nat Cell Biol. 2002 Jan;4(1):83-8.
molnova catalog



related products
-
Myokinasib
Myokinasib is a mixed-type, selective inhibitor of Myosin Light Chain Kinase 1 (MLCK1) with IC50 of 7.9 uM.
-
BHC
BHC (Myosin inhibitor BHC) is a small-molecule screen of skeletal muscle myosin inhibitor.
-
Danicamtiv
Danicamtiv is an inotropic agent and it also is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency.